Alan Lankford

Summary

Publications

  1. ncbi request reprint Armodafinil: a new treatment for excessive sleepiness
    D Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 380, Atlanta, GA 30342, USA
    Expert Opin Investig Drugs 17:565-73. 2008
  2. ncbi request reprint Wireless CPAP patient monitoring: accuracy study
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, Georgia, USA
    Telemed J E Health 10:162-9. 2004
  3. pmc Indiplon in the treatment of sleep disorders
    Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA, USA
    Neuropsychiatr Dis Treat 3:765-73. 2007
  4. doi request reprint Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia
    Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 380, Atlanta, GA 30342, USA
    Sleep Med 13:133-8. 2012
  5. ncbi request reprint Sublingual zolpidem tartrate lozenge for the treatment of insomnia
    Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 548, Atlanta, GA 30342, USA
    Expert Rev Clin Pharmacol 2:333-7. 2009
  6. doi request reprint Tasimelteon for insomnia
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, Georgia, USA
    Expert Opin Investig Drugs 20:987-93. 2011
  7. pmc Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA 30342, USA
    Sleep 31:1359-70. 2008
  8. ncbi request reprint Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia
    A Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA, USA
    Int J Clin Pract 61:1037-45. 2007
  9. ncbi request reprint Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss
    D Alan Lankford
    Sleep Disorders Center of Northeast Georgia Medical Center, Gainesville, GA 30342, USA
    Obes Surg 15:336-41. 2005
  10. pmc Efficacy and tolerability of indiplon in transient insomnia
    Russell Rosenberg
    Atlanta Sleep Institute, Atlanta, GA 30342, USA
    J Clin Sleep Med 3:374-9. 2007

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Armodafinil: a new treatment for excessive sleepiness
    D Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 380, Atlanta, GA 30342, USA
    Expert Opin Investig Drugs 17:565-73. 2008
    ..It is the R-enantiomer of the compound modafinil. Like modafinil, the mechanism of action for armodafinil is not fully characterized...
  2. ncbi request reprint Wireless CPAP patient monitoring: accuracy study
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, Georgia, USA
    Telemed J E Health 10:162-9. 2004
    ..Potential benefits of this technology include advanced compliance and efficacy along with a potential reduction in health-care costs...
  3. pmc Indiplon in the treatment of sleep disorders
    Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA, USA
    Neuropsychiatr Dis Treat 3:765-73. 2007
    ..In May 2006, the FDA indicated that indiplon-IR was approvable and plans are to resubmit the application in 2007. Indiplon-MR was unapprovable and may require further evaluation...
  4. doi request reprint Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia
    Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 380, Atlanta, GA 30342, USA
    Sleep Med 13:133-8. 2012
    ..The efficacy and safety of doxepin (DXP), a histamine H(1) receptor antagonist, was evaluated in elderly adults with sleep maintenance insomnia...
  5. ncbi request reprint Sublingual zolpidem tartrate lozenge for the treatment of insomnia
    Alan Lankford
    Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 548, Atlanta, GA 30342, USA
    Expert Rev Clin Pharmacol 2:333-7. 2009
    ..SZT is currently being reviewed by the US FDA for potential approval for insomnia characterized by middle-of-the-night awakenings with difficulty returning to sleep...
  6. doi request reprint Tasimelteon for insomnia
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, Georgia, USA
    Expert Opin Investig Drugs 20:987-93. 2011
    ..Tasimelteon is a melatonin receptor agonist developed by Bristol-Myers Squibb Co. and later licensed to Vanda Pharmaceuticals in 2004. It is being developed for the treatment of sleep disorders, including insomnia and mood disorders...
  7. pmc Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies
    D Alan Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA 30342, USA
    Sleep 31:1359-70. 2008
    ..To evaluate the efficacy and tolerability of gaboxadol in the treatment of adult and elderly patients with primary insomnia...
  8. ncbi request reprint Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia
    A Lankford
    Sleep Disorders Center of Georgia, Atlanta, GA, USA
    Int J Clin Pract 61:1037-45. 2007
    ..As of May 2006 indiplon-IR has been provisionally approved for use in the US market and discussions are continuing with the FDA regarding the MR formulation...
  9. ncbi request reprint Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss
    D Alan Lankford
    Sleep Disorders Center of Northeast Georgia Medical Center, Gainesville, GA 30342, USA
    Obes Surg 15:336-41. 2005
    ..We evaluated the CPAP pressure requirements in a group of patients undergoing rapid weight loss following Roux-en-Y gastric bypass...
  10. pmc Efficacy and tolerability of indiplon in transient insomnia
    Russell Rosenberg
    Atlanta Sleep Institute, Atlanta, GA 30342, USA
    J Clin Sleep Med 3:374-9. 2007
    ..The efficacy of indiplon was evaluated by polysomnography (PSG) in an experimental model of transient insomnia consisting of the first night effect combined with a 2-hour phase advance...
  11. ncbi request reprint Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial
    R Bruce Lydiard
    Department of Neuropsychiatny and Behavioral Science University of South Carolina, Columbia, SC, USA
    J Clin Sleep Med 2:309-15. 2006
    ..The aim of the present study was to evaluate the efficacy and safety of a 15-mg nightly dose of modified-release indiplon tablets in elderly patients with primary insomnia characterized by sleep-maintenance difficulties...